PEAR THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -99.00% |
|
-.--% | -.--% |
| 22/03 | Disclosure Statement and Plan Approved on Interim Basis for Pear Therapeutics, Inc. | CI |
| 04/03 | Combined Liquidation Plan and Disclosure Statement Filed by Pear Therapeutics, Inc. | CI |
Chart calendar Pear Therapeutics, Inc.
24f5c5e0.J4IwuhDxSY8GDk7b_UihziuClQit7lMY9HlmD-2X8lc.SuQF3COFL-hNZhS9vynN_WrExlueowZsmQ0sY73RgjUK-x32YqY4zEdFLQ~0e9b2707a5fea690f16127a4d1f72880
Past events on Pear Therapeutics, Inc.
| 06/03/2023 07:40 pm | Cowen Health Care Conference |
| 14/02/2023 | BTIG MedTech Digital Health Life Science & Diagnostic Tools Conference |
| 30/11/2022 10:40 pm | Evercore ISI HealthCONx Conference |
| 21/11/2022 08:30 pm | BTIG Digital Health Forum |
| 15/11/2022 03:00 am | Q3 2022 Earnings Call |
| 15/11/2022 02:32 am | Q3 2022 Earnings Release |
| 09/11/2022 04:45 am | Credit Suisse Healthcare Conference |
| 20/09/2022 10:00 pm | LifeSci Partners HealthTech Symposium - Fireside Chat |
| 14/09/2022 11:35 pm | Morgan Stanley Global Healthcare Conference |
| 12/08/2022 02:00 am | Interim 2022 Earnings Call |
| 12/08/2022 01:32 am | Interim 2022 Earnings Release |
| 23/06/2022 10:10 pm | Cowen Future Health Conference - Panel |
| 14/06/2022 07:30 pm | Annual General Meeting |
| 10/06/2022 07:00 pm | Jefferies Healthcare Conference |
| 06/06/2022 07:30 pm | Investor Day |
| 04/06/2022 | Associated Professional Sleep Societies Meeting |
| 18/05/2022 05:30 pm | Needham Tech & Media Conference |
| 17/05/2022 02:00 am | Q1 2022 Earnings Call |
| 17/05/2022 01:32 am | Q1 2022 Earnings Release |
| 10/05/2022 11:10 pm | Bank of America Healthcare Conference - Fireside Chat |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9,38 | 4,21 4,41 -4.69% | 12,7 14,7 -13.43% |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -104 -98,9 -5.12% | -120 -113 -5.9% |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -106 -101 -4.89% | -123 -117 -5.78% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -65,1 -115 43.58% | -75,5 -83,3 9.34% |
|
Net income Million USD | Released Forecast Spread | 0,00 | -65,1 -115 43.56% | -75,5 -83,3 9.34% |
|
EPS USD | Released Forecast Spread | -7,32 | -0,57 -2,87 80.15% | -0,54 -0,57 5.59% |
| Announcement Date | 08/09/21 | 28/03/22 | 31/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,32 1,42 -7.27% | 2,75 2,40 14.7% | 3,30 4,24 -22.16% | 4,08 4,34 -5.83% | 2,57 4,60 -44.22% |
|
EBITDA Million USD | Released Forecast Spread | -33,6 -28,7 -17.15% | -33,9 -30,8 -9.96% | -31,8 -32,1 0.77% | -25,6 -28,1 8.77% | -28,2 -24,7 -14.48% |
|
EBIT Million USD | Released Forecast Spread | -34,2 -30,0 -14.28% | -34,7 -32,5 -6.79% | -32,8 -33,6 2.31% | -26,6 -30,3 12.13% | -29,2 -24,2 -20.31% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 18,8 -30,2 162.09% | -23,9 -32,0 25.44% | 5,46 -34,1 116.02% | -30,7 -29,8 -3.1% | -26,4 -25,9 -1.82% |
|
Net income Million USD | Released Forecast Spread | 18,8 -32,1 158.37% | -23,9 -31,4 23.91% | 5,46 -35,6 115.35% | -30,7 -29,9 -2.84% | -26,4 -27,4 3.66% |
|
EPS USD | Released Forecast Spread | 0,13 -0,42 130.77% | -0,17 -0,24 28.02% | 0,04 -0,25 116.26% | -0,22 -0,22 -1.45% | -0,19 -0,23 17.12% |
| Announcement Date | 28/03/22 | 16/05/22 | 11/08/22 | 14/11/22 | 31/03/23 |
| 07/05/2024 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
| 07/05/2024 | VERVE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | OLEMA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | BEAM THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | PHARVARIS N.V.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | IDEAYA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | SANA BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | NOVAVAX, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 10:30 am | VALNEVA: Q1 2024 Earnings Release |
| 07/05/2024 04:30 pm | IONIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Past sector events for Pear Therapeutics, Inc.
| 03/05/2024 01:40 am | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 05:30 pm | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:35 pm | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:00 pm | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PEARQ Stock
- Calendar Pear Therapeutics, Inc.
